| Autor: |
White, William B., Bakris, George L., Caralis, Dennis G. |
| Zdroj: |
Lower Extremity Arterial Disease; 2005, p223-242, 20p |
| Abstrakt: |
The new millennium found lower extremity arterial disease (LEAD) and intermittent claudication in particular, pharmacotherapeutically orphan. Pharmacologically, intermittent claudication has been an orphan since it was first described many decades ago. Intermittent claudication, the cardinal symptom of LEAD occurs in 35 to 50% of patients with known LEAD documented by noninvasive diagnostic methods (1). The development of effective pharmacotherapy for treating claudication has lagged behind that for treating angina pectoris and other manifestations of myocardial ischemia. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
